Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Blujepa. Always confirm against the full prescribing information.
100 interactions
Acebutolol
The risk or severity of QTc prolongation can be increased when Gepotidacin is combined with Acebutolol.
Level 1 evidence
Aclidinium
The therapeutic efficacy of Aclidinium can be decreased when used in combination with Gepotidacin.
Level 1 evidence
Acrivastine
The risk or severity of QTc prolongation can be increased when Gepotidacin is combined with Acrivastine.
Level 1 evidence
Adagrasib
The risk or severity of QTc prolongation can be increased when Gepotidacin is combined with Adagrasib.
Level 1 evidence
Adenosine
The risk or severity of QTc prolongation can be increased when Gepotidacin is combined with Adenosine.
Level 1 evidence
Albuterol
The risk or severity of QTc prolongation can be increased when Gepotidacin is combined with Albuterol.
Level 1 evidence
Alcaftadine
The risk or severity of QTc prolongation can be increased when Gepotidacin is combined with Alcaftadine.
Level 1 evidence
Alfuzosin
The risk or severity of QTc prolongation can be increased when Gepotidacin is combined with Alfuzosin.
Level 1 evidence
Amantadine
The therapeutic efficacy of Amantadine can be decreased when used in combination with Gepotidacin.
Level 1 evidence
Amifampridine
The risk or severity of QTc prolongation can be increased when Gepotidacin is combined with Amifampridine.
Level 1 evidence
Amisulpride
The risk or severity of QTc prolongation can be increased when Gepotidacin is combined with Amisulpride.
Level 1 evidence
Amitriptyline
The therapeutic efficacy of Amitriptyline can be decreased when used in combination with Gepotidacin.
Level 1 evidence
Enter your NPI to unlock 11 major interactions for Blujepa
Blujepa (Gepotidacin) has 362 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Blujepa (Gepotidacin) has 44 major, 312 moderate, and 6 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Blujepa. Always confirm against the full prescribing information.